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Abstract
Background: The nonstructural protein 1 (NS1) of influenza A viruses can act as a viral replication enhancer by
antagonizing type I interferon (IFN) induction and response in infected cells. We previously reported that A/Puerto
Rico/8/1934 (H1N1) (PR8) containing the NS1 gene derived from A/swine/IA/15/1930 (H1N1) (IA30) replicated more
efficiently than the wild type virus. Here, we identified amino acids in NS1 critical for enhancing viral replication.
Methods: To identify a key amino acid in NS1 which can increase the virus replication, growth kinetics of PR8
viruses encoding single mutation in NS1 were compared in A549 cells. NS1 mutant functions were studied using
dsRNA-protein pull down, RIG-I mediated IFNβ-promoter activity assays and growth curve analysis in murine lung
epithelial type I (Let1) cells.
Results: The G45R mutation in the NS1 of PR8 (G45R/NS1) virus is critical for the enhanced viral replication in A549
cells. G45R/NS1 slightly decreased NS1 binding to dsRNA but did not interfere with its suppression of RIG-I-
mediated type I IFN production. Likewise, replication of G45R/NS1 virus was increased in comparison to wild type
virus in both wild type and type I interferon receptor null Let1 cells.
Conclusions: The non-conserved amino acid, R45, enhances viral replication which is apparently independent of
dsRNA binding and suppression of type I IFN, suggesting a non-characterized function of NS1 for the enhanced
viral replication. As G45R/NS1 virus induced the type I IFN induction and response in infected A549 cells, it is also
interesting to investigate virus virulence for further studies.
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Background
Influenza A virus has evolved a variety of mechanisms to
evade host cell defenses to facilitate efficient transmis-
sion [1, 2], replication and virulence [3]. Escape from
host innate immune responses allows influenza A virus
to proficiently replicate in the cells. The most important
innate immune response against influenza A virus is the
interferon (IFN) system [4]. There are three types of IFN
families including type I (−α, − β, −ω and -ɛ), type II
(−γ) and type III (−λs or IL28/29) [5]. Type I IFNs, espe-
cially -α/β, are essential for host defense against viral in-
fection. It is induced following the recognition of viral
components or RNA by pathogen recognition receptors
(PRRs) such as retinoic acid-inducible gene I (RIG-I) in
the cytoplasm and toll-like receptors (TLR) in the endo-
some and on the cell surface [6–8].
IFN signaling is mediated via binding between IFN
and its receptor, which triggers downstream signaling via
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Janus Activated Kinase (JAK) and Tyrosine Kinae-2
(TYK2) followed by Signal Transducer and Activators of
Transcription (STAT) proteins [9]. After activation, STATs
translocate into the nucleus to initiate transcription of
IFN-stimulated genes (ISGs), such as 2’-5’oligoadenylate
synthetase (OAS1), dsRNA-dependent protein kinase R
(PKR) and Mx1, which have antiviral functions [10, 11].
The non-structural protein 1 (NS1) of influenza A
virus plays an important role in counteracting the IFNα/
β system [12], thereby preventing the generation of an
antiviral state in the cell and facilitating efficient viral rep-
lication [13, 14]. This action of NS1 was shown at multiple
levels in vitro and is different among influenza A virus
strains [15]. NS1 contains two major functional domains,
an N-terminal RNA-binding domain (RBD), which binds
dsRNA, and a C-terminal effector domain (ED). The RBD
has been proposed to sequester dsRNA from RIG-I [16]
and dsRNA-activated antiviral enzymes such as OAS1
[17] and PKR [18, 19] to prevent their antiviral activities.
Previously, we reported that reassortant viruses contain-
ing internal gene segments derived from the A/swine/IA/
15/30 H1N1 virus (IA30) with the hemagglutinin (HA)
and neuraminidase (NA) from the avian influenza virus
H5N1 or swine influenza virus H3N2 replicated more effi-
ciently than those with internal gene segments from A/
Puerto Pico/8/1934 (H1N1) (PR8) in Madin Darby canine
kidney (MDCK) and Vero cells [20]. Among the IA30
genes, IA30 NS has been shown to increase PR8 virus rep-
lication more efficiently than wild type PR8 NS1 [21]. In
this report, we have identified a non-conserved residue of
NS1 that enhanced viral replication independent of its
dsRNA-binding ability and the IFN antagonist function.
Results
The RNA-binding domain of IA30 NS1 increased virus
replication
We reported previously that IA30 replicated to higher ti-
ters than PR8 [20] and it was mediated by the IA30 NS
[21]. In this study, we compared the growth kinetics of
viruses generated by reverse genetics based on X31 con-
taining the HA and NA of A/Hong Kong/1/1968
(H3N2), the PB2, PB1, PA, NP, and M of PR8 and the
NS of either PR8 or IA30. The virus containing IA30 NS
grew to significantly higher titers at 48 and 72 h post in-
fection (hpi) than the virus containing the PR8 NS
(Fig. 1b). To identify the IA30 NS1 domain responsible
for increasing viral replication, we generated viruses
containing chimeric NS genes. Chimera 1 contained the
RBD derived from PR8 NS1 and the ED derived from
IA30 NS1 whilst Chimera 2 contained the RBD derived
from IA30 NS1 and the ED derived from PR8 (Fig. 1a).
Chimera 2 reached significantly higher titers compared
to PR8 NS1 virus, whilst Chimera 1 had a comparable
replication rate to the PR8 NS1 virus (Fig. 1b). These
results indicated that the IA30 RBD was involved in in-
creasing viral replication.
We performed multiple alignments of the deduced amino
acids of both chimeras. The result shows that few amino
acids on NS2 of both chimeras are different. NS2 has a nu-
clear export signal and interacts with M1 via its C-terminal
domain (aa 81–100) to transport the vRNP from nucleus to
cytoplasm for viral assembly (Shimizu et al., 2011) and also
regulates the accumulation of viral RNA species including
viral RNA, cRNA and mRNA, which are important for viral
transcription and replication (Robb et al., 2009). According to
NS2 functions, we cannot exclude that NS2 translated from
chimeric 1 and 2 genes may have an effect on the replication.
A single amino acid substitution, G45R, in PR8 NS1
contributed to enhanced viral replication
To determine amino acids in the RBD of IA30 NS1 that
contributed to increased viral replication, amino acid se-
quences of PR8 and IA30 NS1s were compared. Eight
residues in the RBD were different between the two
strains. We selected four point mutations at positions
45, 55, 68 and 70, which did not affect NS2 expression, to
introduce into the RBD coding region of PR8 NS1 to gen-
erate viruses containing PR8 NS1 with G45R, K55E, I68V
or K70E mutations via reverse genetics [22]. Growth
kinetics of the viruses was assessed in A549 cells at a
multiplicity of infection (MOI) of 0.01. Viruses with NS1
mutations at G45R and K55E (G45R and K55E/NS1s)
grew to higher titers compared to the wild type (WT),
I68V and K70E/NS1s viruses. The G45R/NS1 virus repli-
cated to the highest titer (P ≤ 0.001) at 48 to 96 hpi while
the replication rates of I68V and K70E/NS1s mutants were
similar to the WT/NS1 virus (Fig. 1b). The increased virus
replication with K55E substitution in PR8 NS1 has been
addressed previously for cell-based vaccine production
[23]. As the G45R/NS1 virus replicated to the highest titer,
it was selected for further studies.
G45R/NS1 did not increase binding to dsRNA in vitro
The RBD of NS1 binds to dsRNA to counteract the host
IFN system and facilitate virus replication [16, 17]. As vi-
ruses containing G45R/NS1 replicated at the highest rate,
we sought to elucidate its impact on RNA binding activity
in vitro. To assess the dsRNA binding ability of the G45R/
NS1 protein, the RBD of PR8 NS1 [WT, G45R and the
dsRNA binding deficient mutant R38AK41A (AA)] [13]
were expressed in E. coli. The expressed proteins
were purified by affinity chromatography and used in
the dsRNA-protein pull down assay. WT/NS1 bound
to dsRNA with high affinity while the deficient mutant,
AA/NS1, failed to bind dsRNA (Fig. 2). However, G45R/
NS1 did not increase the binding ability of NS1 compared
to WT/NS1 (Fig. 2). All three replicates of the pull down
reactions performed separately yielded similar results
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(Additional file 1: Fig. S1). Therefore, G45R/NS1 does not
play a significant role in the dsRNA-NS1 interaction in vitro.
G45R/NS1 did not increase inhibition of RIG-I mediated
IFNβ-promoter activation
RIG-I is a cytoplasmic pathogen sensor that is crucial to
recognize viral RNA, particularly 5’-ppp ssRNA and
dsRNA, and trigger type I IFN induction to combat viral
infection [24, 25]. NS1 has been shown to inhibit RIG-I-
mediated IFN induction by forming a complex with
RIG-I partly via the RNA-binding domain [26]. We
assessed whether G45R/NS1 was able to inhibit RIG-I
mediated IFN synthesis in 293 T cells co-transfected
with plasmids including pCAGGS_PR8NS1 (WT, G45R
or AA) or empty pCAGGS as a control, pRIG-I and
pfirefly luciferase driven by the IFNβ promoter and pRe-
nilla Luciferase. RIG-I mediated IFNβ-promoter activa-
tion was measured by dual luciferase reporter assay. The
IFNβ promoter was strongly activated in cells trans-
fected with RIG-I; however, in the presence of NS1,
IFNβ activation was reduced. AA/NS1 was less efficient in
suppressing RIG-I-mediated IFNβ-promoter activity, as
expected (Fig. 3). The inhibition of RIG-I mediated IFNβ-
promoter activity by WT and G45R/NS1 proteins were
similar while the NS1 expressions by each virus in the
transfected cells were not different (Additional file 2: Fig.
S2). This confirmed that the different luciferase signals did
not come from different levels of NS1 expression. There-
fore, the increased replication of G45R/NS1 virus was not
due to NS1-mediated alterations of RIG-I mediated IFNβ-
promoter activation.
Fig. 2 dsRNA-RBD NS1 pull down assay. The G45R/NS1 bound to dsRNA
with lower affinity than the wild type (WT). The R38AK41A as a negative
control failed to bind with dsRNA. The input NS1_RBDs for dsRNA-protein
pulled down assay were loaded and run onto 15 % acrylamide gel. The
input proteins were detected by Coomassie brilliant blue staining
Fig. 1 Schematic diagram of wild type and chimeric NS1 proteins and growth kinetics of reverse genetics viruses, A/Puerto Rico/8/1934 (PR8)
with X31 HA and NA (rX31) encoding wild type (WT) and mutated nonstructural protein 1 (NS1). a Wild type and chimeric NS1 proteins (230
amino acids in length) contain the RNA binding domain (RBD) (amino acid 1–73) and effector domain (EF) (amino acid 74–230). Chimera 1
contains the RBD derived from PR8 NS1 and the ED derived from A/swine/IA/15/1930 NS1 (IA30 NS1) whilst Chimera 2 contains the RBD derived
from IA30 NS1 and the ED derived from PR8. b The viruses containing PR8 NS1, IA30 NS1, chimera 1 or chimera 2, and c PR8 NS1 with a single
amino acid mutation (G45R, K55E, I68V and K70E) were infected in triplicate in A549 cells at an MOI of 0.01. Culture medium was collected every
24 h post infection for virus titration by TCID50 /ml in Madin-Darby canine kidney (MDCK) cells. *, ** and *** represent the statistically significant
differences of mean titers compared to the WT at p < 0.05, p < 0.01 and p < 0.001, respectively, as determined by ANOVA
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G45R/NS1 increased virus replication independent of type
I IFN induction
Our data suggested that the anti-RIG-I activity of the
G45R/NS1 variant was similar to WT NS1. To test this
hypothesis, we infected A549 cells with WT and G45R/
NS1 viruses at an MOI of 1 to measure type I IFN
mRNA expression and single step growth kinetics. As
shown earlier, the G45R/NS1 virus replicated more effi-
ciently than the WT virus, which is particularly apparent
early in infection. Interestingly, the G45R/NS1 virus in-
duced greater expression of IFNα/β mRNA compared to
the WT/NS1 (Fig. 4). As such, G45R/NS1 did not sup-
press type I IFN expression to facilitate virus replication.
Based on these observations we concluded that G45R/
NS1 does not possess type I IFN suppressive activity and
hence is not responsible for the increased G45R/NS1
virus replication. To further evaluate the relevance of
type I IFNs for virus replication, we conducted growth
kinetics experiments using WT, G45R and AA/NS1s vi-
ruses in WT and type I interferon receptor null (IFNAR-
null) murine lung epithelial type I (Let1) cells [27]. If type
I IFNs were involved in the difference between the repli-
cation kinetics of WT and G45R/NS1 viruses, replication
of the G45R/NS1 virus should be greater than the WT/
NS1 virus in WT Let1 cells yet similar in IFNARnull Let1
cells. As shown in Fig. 5, the G45R/NS1 virus replicated
to higher titers compared to the WT/NS1 virus in both
WT and IFNARnull Let1 cells at every time point investi-
gated, further supporting our conclusion that modula-
tion of type I interferon biology, at the level of RIG-I-
induced IFN activation or at later levels of type I inter-
feron activity, is not the reason for the increased replica-
tive capacity of the G45R/NS1 virus observed.
Discussion
The NS1 protein of influenza A virus is multifunctional
and associated with increased viral pathogenicity and
replication by counteracting host antiviral defense mech-
anisms [28]. NS1 inhibits IFNα/β induction and the anti-
viral response through different pathways [4, 15, 29–31],
though some functions are strain-specific [32, 33]. It was
shown previously that recombinant viruses with different
HA and NA subtypes in an IA30 virus background had
much higher replication rates compared to viruses in a
PR8 virus background [20]. Recently, IA30 NS has been
shown to involve in the increased virus replication [21].
Here, we investigated the roles of amino acids in IA30
NS1 in enhancing viral replication. We constructed vi-
ruses using reverse genetics that contained the HA and
NA genes from X31 in a PR8 background and demon-
strated that the single amino acids substitution, G45R,
in the RBD of PR8 NS1 accelerated viral replication.
The RBD of NS1 plays a major role in inhibiting host
defense mechanisms, in particular type I IFN produc-
tion. It may sequester dsRNA from PRRs and ISG prod-
ucts that require activation by dsRNA, such as RIG-I,
PKR and OAS1 [4, 17, 30]. In addition, NS1 also inter-
acts with these proteins to block their functions [19, 24].
Viruses containing the R38A mutation in NS1 were at-
tenuated, lacked dsRNA binding and were sensitive to
IFNβ [23]. However, replication of viruses containing the
R38A NS1 mutation was improved in RNaseL knockout
cells, suggesting that NS1 was involved in the inhibition
of the 2’-5’ OAS/RNaseL pathway, possibly by sequester-
ing dsRNA and preventing activation of OAS1 [23].
Previously, in silico analysis suggested that the R45 on
NS1 of the pandemic virus A/Texas/15/2009 (H1N1) in-
creased the stability of the dsRNA-NS1 complex, which
contributed to viral pathogenicity [34]. We investigated
whether the enhanced viral replication mediated by
G45R/NS1 was due to the increased dsRNA binding in
vitro using dsRNA-NS1 pull-down assays. In these as-
says, G45R/NS1 did not show increased dsRNA-binding
compared to WT/NS1. As G45R/NS1 did not act as pre-
dicted [34], we speculated that substitution of G45R on
PR8 NS1 may impact dsRNA binding by steric hin-
drance. Nonetheless, NS1 functions do not depend
solely on its dsRNA-binding activity. WSN-NS1 with the
triple mutations R38A, K41A and S42G could not bind
to dsRNA similar to R38A and K41A, though the virus
containing R38A, K41A and S42G decreased activation
of the IFNβ promoter and had a higher replication rate
compared to the virus containing R38A and K41A [13].
Fig. 3 RIG-I mediated IFNβ-promoter activity in 293 T cells expressing
PR8 NS1 (wild type; WT, G45R and R38AK41A; AA), RIG I and IFNβ-
promoter luciferase reporter at 24 h post infection. WT and G45R NS1s
decreased the luciferase expression in dose-dependent manner by
inhibition of RIG-I mediated IFNβ-promoter activity. The double mutant
R38AK41A served as a negative control failed to inhibit RIG I mediated
luciferase expression via IFNβ-promoter. *** represents the statistically
significant difference of mean luciferase activity compared to the WT
and G45R at p < 0.001, as determined by ANOVA
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RIG-I is a crucial cytoplasmic sensor for dsRNA and
5’ppp-ssRNA that triggers downstream signaling to acti-
vate type I IFN production during virus infection [24, 25].
It has been reported that NS1 interferes with the RIG-I
mediated IFN pathway partly through its RBD, increasing
viral replication and pathogenicity [35, 36]. We investigated
whether G45R/NS1 increased virus replication by
inhibiting RIG-I mediated IFNβ-promoter activation.
The reporter assay showed that G45R/NS1 suppressed
the activation of IFNβ-promoter comparable to WT/
NS1 (Fig. 3). We suggest that the G45R mutation in
PR8 NS1 facilitated virus replication independent of
Fig. 5 Replication kinetics of the rX31 virus encoding PR8 NS1s (WT, G45R or R38AK41A (AA)) in wild type (WT) and type I IFN receptor null
(IFNARnull) Let1 cells. rX31 with G45R replicated to significantly higher titer that WT in both a WT and b IFNARnull Let1 cells. The virus with RNA
binding deficient NS1, AA, could not replicate well in both cell types. *** represents the statistically significant difference of mean titers compared
to the WT at p < 0.001, as determined by ANOVA
Fig. 4 Expression of type I IFN and NS1 in rX31 infected A549 cells and rX31 growth kinetics. a The expression levels of IFNα, IFNβ and NS1 in
A549 cells infected with rX31 virus encoding WT or G45R NS1 at 8 h post infection. rX31 with G45R NS1 induced significantly high level of IFNα,
IFNβ and NS1 expression compared to the WT virus. Graphs represent mean ± SEM, * and ** represent the statistically significant difference of
mean relative mRNA expression compared to the WT at p < 0.05 and p < 0.01, respectively, as determined by student t-test. b Growth of rX31
viruses encoding PR8 NS1 (WT and G45R). rX31 virus with G45R NS1 also replicated to significantly high titer compared to the WT virus early in
infection. ** represents the statistically significant difference of mean titers compared to the WT at p < 0.01, as determined by ANOVA
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dsRNA-binding and RIG-I mediated IFNβ promoter
activation.
We confirmed that type I IFNs induction was not rele-
vant to G45R/NS1 virus replication by using IFNARnull
Let1 cells. G45R/NS1 replicated to higher titers com-
pared to WT virus while AA/NS1 virus was attenuated
in both WT and IFNARnull Let1 cells (Fig. 5) suggesting
that G45R/NS1 strongly influenced virus replication in a
type I IFN induction-independent manner. In fact, high
replication of G45R/NS1 was accompanied by increased
type I IFN and STAT1 phosphorylation (Fig. 4 and
Additional file 3: Fig. S3), conferring a strong activation
of type I IFN signaling. Elevation of type I IFN expres-
sion can up-regulate the expression of various cytokines
and chemokines to recruit immune cells to the site of
infection. In addition, IFNα has been reported to en-
hance CCL5 and CCL10 expression in influenza virus-
infected A549 cells [37]. Rapid virus replication, systemic
spread and activation of IFNα/β signaling by influenza
virus infection could lead to excessive production of cy-
tokines and chemokines, resulting in increased morbid-
ity and mortality in mice [38, 39]. An adaptation of
amino acids on NS1, F103L and M106I, of human influ-
enza A/Hong Kong/1/68(H3N2) has been reported to be
associated with the increased virus replication and viru-
lence in mice and human [40] thereby the occurrence of
G45R mutation on NS1 of pandemic human 2009 H1N1
virus might be one of crucial factors to cause severe dis-
ease. Even though G45R in NS1 presents in a minor
population of the pandemic H1N1 2009 viruses, it has
been proposed that G45R mutation might be related to
the increased cytokine production observed during in-
fections by these viruses [41].
Conclusions
We elucidated the function of the non-conserved amino
acid, R45, in NS1, which facilitated viral replication by
an undefined mechanism. G45R/NS1 does not increase
the efficiency of binding to dsRNA or suppress IFNβ in-
duction, which are the established functions of NS1.
Thus, increased viral replication of G45R/NS is inde-
pendent of dsRNA binding and type I IFN induction,
suggesting that a non-characterized function of NS1 was
responsible for the enhanced viral replication observed
in this study. As we have demonstrated that G45R/NS1
virus induced the type I IFN induction and response in
infected A549 cells, it is also interesting to investigate
virus virulence for further studies.
Methods
Cells lines
Human embryonic kidney (293 T), human lung carcin-
oma (A549) and Mardin-Darby canine kidney (MDCK)
cells were cultured in Opti-MEM I reduced serum
medium (Gibco, Invitrogen), Kaighn’s Modification of
Ham’s F-12 Medium (ATCC) or minimum essential
media (Invitrogen), respectively, supplemented with 5 %
fetal bovine serum (Invitrogen), L-glutamine (Invitro-
gen), penicillin and streptomycin (Invitrogen). Murine
lung epithelial type I cell line (Let1; wild type or type I
IFN receptor null, IFNARnull), kindly provided by Alan
Aderem and Alan Diercks [27], was cultured in Dulbec-
co’s Modified Eagle Medium (Invitrogen) supplemented
with 10 % fetal bovine serum, penicillin and strepto-
mycin. All cells were incubated in a humidified atmos-
phere of 5 % CO2 at 37 °C.
Construction of plasmids
Two chimeric NS genes—chimera 1 and chimera
2—comprising the 3’UTR and RBD of PR8 NS1 (amino
acid 1–73) and the effector domain (ED) (amino acid
74–230) and 5’ UTR derived from IA30 NS1 or vice
versa were amplified from plasmids containing full-
length NS genes of both strains [20] using a fusion PCR
technique with a pair of specific primers. This strategy
was designed to keep the NS2 transcripts intact. To
make a single point mutation on NS1 protein of PR8,
the NS1 sequences of PR8 and IA30 were compared to
determine the different amino acids between the two
strains. Four different amino acids on RBD were selected
and a single point mutation was introduced into PR8 NS
gene using specific primers. Amino acids at position 45,
55, 68 or 70 of PR8 NS1 were replaced with those of
IA30. The mutations did not interfere with NS2 expres-
sion as they are spliced out to generate the mature
mRNA. The dsRNA-binding deficient NS1, R38AK41A
(AA) was constructed using similar strategies. The mu-
tated NS genes were digested and inserted into the bidir-
ectional vector pHW2000 [22].
The RBD (amino acids 1–73) of PR8 NS1 genes were
cloned into the pQE80L vector (Qiagen) for protein ex-
pression in E. coli strain BL21. The DNA sequences in
the positive clones were verified by DNA sequencing
(Macrogen, Korea).
Generation of viruses by reverse genetics
The viruses used in this study were generated by trans-
fection using the eight-plasmid reverse genetics system
in 293 T and MDCK cells as described previously [20,
42]. The plasmids used were as follows; NS1 from PR8
(WT or mutated PR8 NSs; G45R, K55E, I68V, K70E and
AA), HA and NA from X31 or A/Hong Kong/1/1968
(H3N2) and the remaining five genes were from PR8.
Briefly, 0.5 μg of each of the eight plasmids were incu-
bated with 12 μl of X-tremeGENE9 transfection reagent
(Roche) in 200 μl reaction for 15 min before they were
gently overlaid onto a 50:50 293 T-MDCK cell mixture.
The transfected cells were cultured in Opti-MEM I
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reduced serum (Gibco, Invitrogen) containing 1 μg/ml
of TPCK-treated trypsin and incubated at 37 °C with
5 % CO2. The reverse genetics viruses were recovered by
collecting supernatant at 48–72 hpi, which was then
used to inoculate the allantoic cavities of 9-day-old
specific pathogen free (SPF) embryonated chicken eggs.
The existence of the mutation on each NS1 was
confirmed by sequencing.
Virus infection
The rescued viruses with different PR8 NS1 (WT, G45R
or AA/NS1s) were used to infect A549 cells grown in 6-
well plates in triplicate wells at an MOI of 0.01 or 2. The
infected cells were maintained in Kaighn’s Modification
of Ham’s F-12 Medium (ATCC) supplemented with
0.3 % BSA (Sigma-Aldrich), penicillin/streptomycin
(Invitrogen) plus 1 μg/ml of TPCK-treated trypsin and
incubated at 37 °C with 5 % CO2.
The viruses encoding WT, G45R and AA/NS1s were
used to infect WT or IFNARnull Let1 cells grown in 6-well
plates in triplicate at an MOI of 1 or 1. The numbers of
plaque forming units (pfu) in the inoculum were re-
examined by plaque assay to confirm the equality of the
virus in each inoculum (Additional file 4: Fig. S4). The
infected cells were maintained in DMEM (Gibco, Invitro-
gen) supplemented with 0.3 % BSA (Sigma), penicillin/
streptomycin (Gibco, Invitrogen) plus 0.1 μg/ml of TPCK
trypsin (Sigma) and incubated at 37 °C with 5 % CO2. The
cell supernatants were collected at indicated time points.
The viruses collected at each time point were titrated by
tissue culture infectious dose (TCID50) assay in MDCK
cells and calculated as previously described [43].
Expression of NS1 RBD
E. coli strain BL21 transformed with pQE plasmids con-
taining the amino acid 1–73 of the RBD of PR8 NS1 in-
cluding WT or mutants G45R and AA were grown in
Luria broth with 100 mg/ml ampicillin (Invitrogen). Pro-
tein expression was induced with 0.2 mM IPTG (Invitro-
gen) at 37 °C for 18 h. The cells were then pelleted by
centrifugation at 4000 rpm at 4 °C for 20 min. The cell
pellets were mixed well in 30 μl of lysis buffer (1 M Tris,
300 mM NaCl, 1 % Triton X and 1 mM EDTA, pH 8.0).
Subsequently, lysozyme and PMSF were added into the
mixture at the final concentrations of 0.25 mg/ml and
1 mM, respectively. The mixture was vortex-mixed and
incubated on ice for 30 min. The cells suspension was
homogenized by sonication followed by centrifugation at
10,000 g at 4 °C for 20 min and the supernatant contain-
ing the soluble fraction of RBD NS1 was collected. The
proteins were purified using Protino® Ni-TED Resin-
gravity-flow column (Macherey-Nagel) under native
condition and were then concentrated in a 3 kDa-Cen-
trifugal filter units (Millipore). The presentation of His-
RBD NS1 proteins were examined by SDS-PAGE using
15 % acrylamide gels. Western blot analysis was per-
formed using anti-NS1 rabbit hyperimmune serum and
goat anti-rabbit IgG-HRP (Millipore) as primary and
secondary antibodies, respectively.
dsRNA-protein pull down assay
To generate dsRNA labeled with biotin, the biotinylated
sense and antisense single-stranded (ss) RNA were in
vitro transcribed. Briefly, the dsDNA template was pro-
duced by amplification of a 72 bp DNA fragment using
forward and reverse primers containing the promoter se-
quences for the binding of T7 and T3 RNA polymerases,
respectively [44]. The dsDNA fragment was purified
using a DNA purification kit (Qiagen) and used as the
template to produce biotinylated ssRNA by in vitro tran-
scription using the Biotin RNA Labeling Mix (Roche)
plus T7 or T3 RNA polymerase (Promega). The
remaining DNA in the in vitro transcription reaction
was destroyed by using DNase I (Promega) and the bio-
tinylated ssRNA was purified by using ethanol precipita-
tion method. The purified biotinylated T7- and T3-
ssRNA were annealed at room temperature to obtain the
biotinylated dsRNA and kept on ice until used in the
binding reaction.
To optimize the pull down reaction, various concen-
trations of biotinylated dsRNA and NS1 RBD were ex-
amined in a checker board titration. Additional file 5:
Fig. S5 shows an example of the titration results. The
optimal condition was selected. In the pull down assay,
0.4 mg of each purified NS1 was incubated with 0.6 μM
biotinylated dsRNA in 20 μl of binding buffer containing
50 mM Tris–HCl, pH 8.3, 75 mM KCl, 3 mM MgCl2,
8 % (v/v) glycerol, 0.1 % (v/v) Triton® X-100 (Amresco),
1 mM DTT (Invitrogen), 5 μg yeast tRNA (Roche) and
40 Unit RNase OUT (Invitrogen). The reaction mixtures
were incubated at room temperature without agitation
for 30 min. After incubation, the dsRNA-NS1 complex
was pulled down with NeutraAvidinAgarose Resin
(Pierce, Thermo Scientific) by incubation at room
temperature for 45 min. The resin was boiled in Lamelli
sample buffer (Bio-Rad). The pulled-down protein was
separated by using SDS-PAGE in 15 % gel. Western blot
was performed by using anti-NS1 rabbit serum and
goat-anti rabbit IgG-HRP (Millipore) as primary and sec-
ondary antibodies, respectively. The membrane was in-
cubated in Clarity® western ECL substrate (Bio-Rad) for
5 min. The chemiluminescent signal was detected by Fu-
sion® FX imaging analyzer (VilberLourmat).
RIG-I mediated IFNβ-promoter activity assay
The plasmids expressing IFNβ-promoter (−125) firefly
luciferase, Renilla Luciferase vector (pRL-TK; Promega),
RIG-I and each PR8 NS1 (WT, G45R and AA) were co-
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transfected into 293 T cells grown in 24-well plate as
previously described [45] with some modifications.
Briefly, the indicated plasmids were transfected to the
cells using XtremeGene HP transfection reagent (Roche).
At 24 h post transfection (pt), the cells were lysed in pas-
sive lysis buffer (Invitrogen) and subjected for luciferase
activity measurement using dual-luciferase kit following
the manufacturer’s instruction (Promega). The firefly lucif-
erase activity signals were normalized to the Renilla lucif-
erase activity. The experiments were done in triplicate.
NS1 expression levels in transfected cells were shown by
western blot analysis (Additional file 2: Fig. S2).
Quantitative real-time PCR (qRT-PCR)
Total RNA was isolated from A549 cells infected with
the rX31 viruses encoding PR8 NS1 (WTand G45R) using
Trizol® reagent (Invitrogen) following the manufacturer’s
instruction. Total RNA was isolated by using Direct-zol™
RNA MiniPrep (Zymo research). One microgram of total
RNA was reverse transcribed using a high-capacity cDNA
reverse transcription kit (Applied Biosystem). Realtime
PCR was performed by using a 7500 Fast real-time PCR
system (Applied Biosystem). In 15 μl reaction, 0.4 mM of
forward and reverse primers and equal amount of cDNA
were mixed with the SYBR® Select master mix (Applied
Biosystem) according to the manufacturer’s protocol. The
qRT- PCR cycle were conducted under the following con-
ditions: enzyme activation at 95 °C for 2 min followed by
40 cycles of denaturation at 95 °C for 3 s, annealing and
extension at 60 °C for 30 s. Three biological replicates and
two technical repeats were performed for each sample.
The housekeeping gene, β-actin, was used as a reference
control. The data of each sample and negative control
(mock infected cells) were normalized to the reference
using the threshold cycle (2-ΔΔCT) method [46].
Data analysis
Mean titers of the viruses at each time point, luciferase
activity and relative mRNA expression level were com-
pared and statistically calculated using analysis of vari-
ance (ANOVA) and student t-test method. Mean titers
of the viruses as TCID50/ml was converted into base-10
logarithms and plotted against time points and a bar
corresponding to SEM was demonstrated. A difference
was considered significant if the p-value was < 0.05.
Additional files
Additional file 1: Fig. S1. Three replicates of dsRNA-RBD pulled down
assay. 0.6 μM of biotinylated-dsRNA and 0.4 mg NS1-RBDs were used in
the pulled down assay. The assay was performed using similar condition
in three separated reactions. The pulled-down NS1-RBD protein was
electrophoresed through 15 % acrylamide gel and blotted onto a
nitrocellulose membrane. Western blot was performed by using anti-NS1
rabbit serum and goat-anti rabbit IgG-HRP as primary and secondary
antibodies, respectively. The protein was detected by chemiluminescent
method. The G45R bound to dsRNA with lower capacity than the wild
type (WT). The R38AK41A (AA) served as a negative control failed to bind
with dsRNA. (TIFF 305 kb)
Additional file 2: Fig. S2. NS1 expression in transfected 293 T cells as
examined by western blot analysis. At 24 h post transfection, the cells
were lysed in passive lysis buffer (Invitrogen) and subjected for western
blot analysis to measure NS1 levels. The lysates were mixed in Laemmli
sample buffer (Bio-Rad) and denatured at 95 °C for 5 mins prior to
perform SDS-PAGE gel electrophoresis. Immunoblots were probed for
NS1 protein (polyclonal rabbit anti-NS1; Thermoscientific) and β-actin
(rabbit anti-actin antibody; Thermoscientific). Antibodies were detected
by incubation with goat anti-rabbit HRP-linked antibody (Millipore). Lane
1 = empty plasmid; Lanes 2 and 3 =WT and G45R at 0.4 μg; Lanes 4 and
5 =WT and G45R at 0.2 μg. (TIF 105 kb)
Additional file 3: Fig. S3. Western blot analysis of STAT1, pSTAT1 and
NS1 protein. A549 cells were infected with rX31 encoding WT and G45R/
NS1 viruses at an MOI of 2. At 8 h post infection, cell lysates were
clarified by centrifugation at 13,000 rpm for 15 min. The lysates were
mixed in Laemmli sample buffer (Bio-Rad) and denatured at 95 °C for 5
mins prior to perform SDS-PAGE gel electrophoresis. Immunoblots were
probed for STAT1 (purified rabbit anti-Stat1 N-terminus, BD Transduction
Laboratories), pSTAT1 (purified mouse anti-Stat1 pY701 BD Transduction
Laboratories), NS1 (polyclonal rabbit anti-NS1; Thermoscientific) and actin
(purified mouse anti-actin Ab-5; BD Transduction Laboratories). Antibodies
were detected by incubation with goat anti-rabbit (GE healthcare) or
goat anti-mouse HRP-linked antibody (Cell signaling). The immunoblots
were visualized by using ChemiDoc XRS imager (Bio-Rad). Band intensity
of proteins was quantified by using Image Lab version 5.0 (Bio-Rad).
(TIFF 2319 kb)
Additional file 4: Fig. S4. Plaque assay of the virus inoculums. The virus
inoculums (WT and G45R/NS1) at MOI of 0.01 were serially diluted before
they were infected onto MDCK cells to confirm that each inoculum had
equal amount of the virus. Plaque assay of the viruses at 10−5 dilution is
shown. The average virus titers of both WT and G45R/NS1 inoculums are
5× 106 pfu/ml. (TIFF 1781 kb)
Additional file 5: Fig. S5. Checker board titration of dsRNA and
NS1-RBD. Different concentrations of biotinylated-dsRNA and NS1-RBD
were titrated in the dsRNA-protein pulled down assay. The pulled-down
NS1-RBD protein was separated by SDS-PAGE in 15 % acrylamide gel and
blotted onto a nitrocellulose membrane. Western blot was performed
by using anti-NS1 rabbit serum and goat-anti rabbit IgG-HRP as primary
and secondary antibodies, respectively. The protein was detected by
chemiluminescent method. Lanes 1, 2 and 3 are the reactions containing
0.4 μM dsRNA and 0.2, 0.4 and 0.6 mg NS1-RBDs. Lanes 4, 5 and 6 are
the reactions containing 0.6 μM dsRNA and 0.2, 0.4 and 0.6 mg NS1-
RBDs, respectively. N1 and N2 are the negative control reactions without
dsRNA or RBD, respectively. (TIFF 204 kb)
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